Translational Development Acquisition Corp. (TDACU) Total Liabilities (2023 - 2026)
Translational Development Acquisition's (TDACU) quarterly Total Liabilities came in at $6.9 million in Q1 2026, up 8.46% YoY from $6.4 million in Q1 2025, and up 4.82% on a QoQ basis from $6.6 million in Q4 2025.
Translational Development Acquisition Corp. (TDACU) Total Liabilities (2023 - 2026) Analysis & Trends
Translational Development Acquisition (TDACU) has 4 years of Total Liabilities data on file, last reported at $6.9 million in Q1 2026.
- Quarterly Total Liabilities rose 8.46% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (up 8.46% YoY) and the FY2025 annual result came in at $6.6 million, up 5.34% from the prior year.
- Total Liabilities grew to $6.9 million in Q1 2026, from $6.6 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $6.9 million in Q1 2026 to a low of $509679.0 in Q4 2023.
- A 4-year average of $5.6 million and a median of $6.4 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities jumped 1125.83% — and 2025, when it increased 5.34%.
- Tracing TDACU's Total Liabilities over 4 years: stood at $509679.0 in 2023, then jumped by 1125.83% to $6.2 million in 2024, then rose by 5.34% to $6.6 million in 2025, then rose by 4.82% to $6.9 million in 2026.
- The last three Total Liabilities figures came in at $6.9 million (Q1 2026), $6.6 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.90 Mn |
| Dec 31, 2025 | 6.58 Mn |
| Sep 30, 2025 | 6.46 Mn |
| Jun 30, 2025 | 6.32 Mn |
| Mar 31, 2025 | 6.36 Mn |
| Dec 31, 2024 | 6.25 Mn |
| Dec 31, 2023 | 509,679.00 |